 FSD Pharma Inc. NASDAQ:HUGE CSE:HUGE, a life sciences holding company looking at cannabinoid and psychedelic-based medicines, announced it is entering a definitive agreement to acquire Lucid Psycheceuticals Inc. Lucid is a psychedelic pharmaceutical company focused on developing therapies to treat neurodegenerative diseases and mental health disorders. 